• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.16% Nasdaq Up0.14%

    Acceleron Pharma, Inc. (XLRN)

    -NasdaqGM
    24.97 Up 0.14(0.56%) 3:38PM EST - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 4,155   5,719   4,420   3,738  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,155   5,719   4,420   3,738  
    Operating Expenses
    Research Development13,331  14,151  14,779  14,579  
    Selling General and Administrative5,436  4,660  4,700  3,714  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,612) (13,092) (15,059) (14,555)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,755  2,711  485  (3,062)
    Earnings Before Interest And Taxes(11,857)(10,381)(14,574)(17,617)
    Interest Expense -   -   -   -  
    Income Before Tax(11,857)(10,381)(14,574)(17,617)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(11,857)(10,381)(14,574)(17,617)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (11,857) (10,381) (14,574) (17,617)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (11,857) (10,381) (14,574) (17,617)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.